{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28473008",
  "DateCompleted": {
    "Year": "2018",
    "Month": "06",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "06",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2017",
        "Month": "05",
        "Day": "05"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1017/ice.2017.80"
    ],
    "Journal": {
      "ISSN": "1559-6834",
      "JournalIssue": {
        "Volume": "38",
        "Issue": "7",
        "PubDate": {
          "Year": "2017",
          "Month": "Jul"
        }
      },
      "Title": "Infection control and hospital epidemiology",
      "ISOAbbreviation": "Infect Control Hosp Epidemiol"
    },
    "ArticleTitle": "Susceptibility of Nosocomial Staphylococcus aureus to Chlorhexidine After Implementation of a Hospital-wide Antiseptic Bathing Regimen.",
    "Pagination": {
      "StartPage": "873",
      "EndPage": "875",
      "MedlinePgn": "873-875"
    },
    "Abstract": {
      "AbstractText": [
        "Hospital use of chlorhexidine (CHX) containing antiseptics to decrease nosocomial infections may promote CHX resistance among pathogenic organisms. Nosocomial bloodstream-infecting Staphylococcus aureus isolates from before and after adoption of hospital-wide CHX bathing were tested for CHX susceptibility, and no decreased susceptibility or resistance-promoting genes were discovered. Infect Control Hosp Epidemiol 2017;38:873-875."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "1Department of Internal Medicine/Division of Infectious Diseases,University of Nebraska Medical Center,Omaha,Nebraska."
          }
        ],
        "LastName": "Marolf",
        "ForeName": "Cole T",
        "Initials": "CT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "2Department of Pathology and Microbiology,University of Nebraska Medical Center,Omaha,Nebraska."
          }
        ],
        "LastName": "Alter",
        "ForeName": "Roxanne",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "3Department of Epidemiology,University of Nebraska Medical Center,Omaha,Nebraska."
          }
        ],
        "LastName": "Lyden",
        "ForeName": "Elizabeth",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "2Department of Pathology and Microbiology,University of Nebraska Medical Center,Omaha,Nebraska."
          }
        ],
        "LastName": "Fey",
        "ForeName": "Paul D",
        "Initials": "PD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "1Department of Internal Medicine/Division of Infectious Diseases,University of Nebraska Medical Center,Omaha,Nebraska."
          }
        ],
        "LastName": "Rupp",
        "ForeName": "Mark E",
        "Initials": "ME"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Infect Control Hosp Epidemiol",
    "NlmUniqueID": "8804099",
    "ISSNLinking": "0899-823X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents, Local"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Bacterial Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Membrane Transport Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "QacB protein, Staphylococcus aureus"
    },
    {
      "RegistryNumber": "134773-66-3",
      "NameOfSubstance": "qacA protein, Staphylococcus aureus"
    },
    {
      "RegistryNumber": "R4KO0DY52L",
      "NameOfSubstance": "Chlorhexidine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents, Local"
    },
    {
      "QualifierName": [
        "microbiology",
        "prevention & control"
      ],
      "DescriptorName": "Bacteremia"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Bacterial Proteins"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Baths"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Chlorhexidine"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Drug Resistance, Bacterial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hospitals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Membrane Transport Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microbial Sensitivity Tests"
    },
    {
      "QualifierName": [
        "microbiology",
        "prevention & control"
      ],
      "DescriptorName": "Staphylococcal Infections"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics"
      ],
      "DescriptorName": "Staphylococcus aureus"
    }
  ]
}